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Abstract
Chemcatcher® and POCIS passive sampling devices are widely used for monitoring polar organic pollutants in water.
Chemcatcher® uses a bound Horizon Atlantic™HLB-L sorbent disk as receiving phase, whilst the POCIS uses the samematerial
in the form of loose powder. Both devices (n = 3) were deployed for 21 days in the final effluent at three wastewater treatment
plants in South Wales, UK. Following deployment, sampler extracts were analysed using liquid chromatography time-of-flight
mass spectrometry. Compounds were identified using an in-house database of pharmaceuticals using a metabolomics workflow.
Sixty-eight compounds were identified in all samplers. For the POCIS, substantial losses of sorbent (11–51%) were found during
deployment and subsequent laboratory analysis, necessitating the use of a recovery factor. Percentage relative standard deviations
varied (with 10 compounds exceeding 30% in both samplers) between individual compounds and between samplers deployed at
the three sites. The relative performance of the two devices was evaluated using the mass of analyte sequestered, measured as an
integrated peak area. The ratio of the uptake of the pharmaceuticals for the POCIS versus Chemcatcher® was lower (1.84x) than
would be expected on the basis of the ratio of active sampling areas (3.01x) of the two devices. The lower than predicted uptake
may be attributable to the loose sorbent material moving inside the POCIS when deployed in the field in the vertical plane. In
order to overcome this, it is recommended to deploy the POCIS horizontally inside the deployment cage.
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Introduction
Monitoring of various types of pollutants in water bodies is
now of a global concern. The environmental concentration of
several chemicals is regulated (i.e. have associated environ-
mental quality standards) within various legislative directives
and frameworks (e.g. European Union’s Water Framework
Directive, (WFD)) (EC 2000). Many other substances are un-
regulated and are increasingly becoming of emerging environ-
mental concern. For example, most pharmaceuticals, their me-
tabolites and personal care products are unregulated (Archer
et al. 2017; Petrie et al. 2015). Such classes of compounds are
common in surface waters due to their continual discharge
from wastewater treatment plants (WWTP) and other sources
(e.g. aquaculture) (Archer et al. 2017; Petrie et al. 2015).
There are over 5000 pharmaceutical products approved for
use in Europe, yet typically, only a few hundred active com-
pounds present in the products have beenmonitoring regularly
in surface waters (Hughes et al. 2013). There is, therefore, a
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clear need for increased investigative monitoring activities to
understand the occurrence and fate of these compounds and to
ascertain the environmental risks that they may pose (Kosma
et al. 2016; Petrie et al. 2013; Daughton 2016). In order to
achieve this, advanced, high confidence, analytical workflows
are needed to screen (e.g. targeted and untargeted analyses) for
the presence or absence of a wide range of pollutants. Such
analyses rely on the use of high-resolution accurate mass sys-
tems including, time-of-flight (TOF), quadrupole time-of-
flight (Q-TOF) and Orbitrap instruments (Rimayi et al.
2019; Pinasseau et al. 2019; Abdallah et al. 2019). The use
of high-resolution mass spectrometry is essential in order to
obtain data on molecular ions, isotope patterns and fragment
ions from the highly complex extracts, which contain numer-
ous substances many of which will have similar molecular
masses. When coupled to ultra-high performance liquid chro-
matography detection limits in the low ng L−1 range can be
achieved using these systems (Acena et al. 2015).
In parallel to these sophisticated analytical protocols, effec-
tive environmental monitoring strategies are also needed to
collect representative water samples. Most routine monitoring
procedures rely on the infrequent (typically monthly) collec-
tion of low-volume (~ 1 L) spot (bottle or grab) samples of
water. This approach has a number of shortcomings when the
concentration of substances is known to fluctuate widely or
there are stochastic inputs of pollutants over time (Castle et al.
2018a; Castle et al. 2019; Townsend et al. 2018). In order to
overcome some of these difficulties, alternative monitoring
strategies, such as the use of passive sampling devices has
been proposed (Vrana et al. 2005). These devices are low-cost,
non-mechanical and relatively simple in design; all have a
receiving phase material with a high affinity for the chemical
being monitored. Samplers can be deployed in the field for
extended times (e.g. days to months) to continuously seques-
ter pollutants. These devices can be used in various modes. In
the qualitative mode, they can be used simply to screen for the
presence or absence of pollutants (Rimayi et al. 2019). In the
quantitative mode, they can yield time-weighted average
(TWA) (Castle et al. 2018a; Castle et al. 2019; Townsend
et al. 2018) or equilibrium concentrations (Vrana et al.
2005). To achieve this, the compound-specific sampler uptake
rate (Rs, mL day
−1), diffusion coefficient or the sample/water
partition coefficient (Ksw) needs to be determined previously
in either the laboratory or in situ in the field (Booij et al. 2007;
Castle et al. 2018b; Petrie et al. 2016). Awide range of devices
now exists capable of sequestering most classes of environ-
mental pollutants (Vrana et al. 2005). For non-polar pollut-
ants, semi-permeable membranes devices (SPMDs) or more
recently polymeric sheets (e.g. low-density polyethylene or
silicone rubber) are used with or without added performance
reference compounds (PRCs) (Lohmann et al. 2012; Taylor
et al. 2019). For semi-polar and polar moieties, three designs
of the sampler are typically used; the polar organic compound
integrative sampler (POCIS) (Godlewska et al. 2019), the po-
lar version of the Chemcatcher® (Petrie et al. 2016), and more
recently the organic version (o-DGT) of the diffusion gradi-
ents in thin film device (Challis et al. 2016).
The POCIS was designed to sequester polar analytes (~log
Kow 0.1–3.0), although semi-polar compounds with higher
values (e.g. hormones and steroids) have also been shown to
accumulate (Alvarez et al. 2013; Creusot et al. 2014). It com-
prises a loose receiving phase sorbent (typically 200 mg in the
standard device) enclosed between two diffusion membranes
(usually microporous polyethersulphone (PES), 0.1 μm pore
size). To prevent loss of sorbent in use, two ‘O’ rings (typi-
cally stainless steel) are used to firmly sandwich the PES
membranes. These rings are fixed in place using nuts and bolts
(Alvarez et al. 2004). Larger substances (cross-sectional di-
ameters > 0.1 μm) such as bacteria, macromolecules and par-
ticulatematerial, are therefore, excluded from sequestration by
the device (Petty et al. 2004). Due to the low-energy surface
properties of the PES, biofouling on the surface of the mem-
brane is also minimised during extended field deployments.
The standard device has an effective sampling surface area of
45.8 cm2 (Godlewska et al. 2019). Two designs of POCIS are
frequently used, each having a different receiving phase sor-
bent. A configuration for hormones, pesticides and chemicals
found in wastewater comprises a tri-phasic mixture of Isolute
ENV+ polystyrene divinylbenzene resin (80% by weight) and
Ambersorb 1500 carbon, lightly dispersed on S-X3 Biobeads
(20% by weight) (Godlewska et al. 2019). The ‘pharmaceuti-
cal POCIS’ contains only a hydrophilic–lipophilic balanced
sorbent (Waters Oasis® HLB). This water-wettable–reversed-
pha s e so rben t comp r i s e s a mac ropo rou s po l y
(divinylbenzene-co-N-vinylpyrolidone) polymer. It exhibits
both hydrophilic and lipophilic retention characteristics and
is capable of adsorbing both polar and semi-polar compounds
(Godlewska et al. 2019). Oasis® HLB is the most frequently
used sorbent and has been used for monitoring industrial
chemicals, pesticides, pharmaceuticals and personal care
products (García-Córcoles et al. 2019). Typical sampler de-
ployment periods are 14–21 days, but longer periods (~
30 days) have been reported (Morin et al. 2012).
The polar Chemcatcher® is similar in construction, com-
prising a three-component PTFE body, and a bound receiving
phase that is overlaid with a thin PES diffusion membrane
(0.2 μm pore size, 47 mm diameter) (Vrana et al. 2007). The
current commercially available version has an active sampling
area of 15.2 cm2. Several types of immobilised receiving
phase have been used, including 3 M Empore™ disks (e.g. a
47-mm modified styrene-divinylbenzene (SDB-RPS or SDB-
XC) or anion-exchange sorbent disk (Charriau et al. 2016;
Lissalde et al. 2016; Townsend et al. 2018) and more recently
the Horizon™ Technology Atlantic disk (e.g. a 47 mmOasis®
HLB-L disk) (Petrie et al. 2016). For most applications, de-
ployment periods ranged from 7 to 30 days, with 14 days
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being the most common (Castle et al. 2018b; Lissalde et al.
2016; Townsend et al. 2018). The accumulation of specific
compounds into the device is altered by the choice of receiv-
ing phase sorbent used.
Recently, an organic version of the well-established DGT
sampler has been developed (Challis et al. 2016). The o-DGT
is made from several layers where compound uptake rates are
different. During the deployment, analytes diffuse through the
diffusive boundary layer and a material diffusion layer com-
prising a filter membrane and hydrogel; lastly, a specific bind-
ing layer sequesters the compound. o-DGT has been used to
measure various organic compounds such as bisphenols, pes-
ticides and phenols, using various binding material such as
activated charcoal, Oasis® HLB, Oasis® HLB-MAX, and a
molecularly imprinted polymer (Challis et al. 2016; Dong
et al. 2014; Guibal et al. 2017; Zheng et al. 2015). The sampler
has a normalised surface area sampling rate of between 0.54–
5.74 mL day−1 cm−2 that is comparable with the other designs
of polar passive samplers. A benefit of the o-DGT over other
passive samplers is that a simpler calibration is needed. In this
case, the diffusional characteristics of individual compounds
are obtained in the laboratory as a fundamental physical prop-
erty (Challis et al. 2016).
Although many field studies have been undertaken with
these three designs of polar devices, there has been very little
work directly comparing their functionalities. Challis et al.
(2018) investigated the field performance (for the uptake of
pharmaceuticals and polar pesticides in an agricultural river
catchment in Manitoba, Canada) of the POCIS alongside the
o-DGT together with the collection of spot samples of water.
Results showed that there was an underestimation (2.3-fold)
of concentrations with the POCIS compared with the o-DGT.
This was likely due to the water flow and boundary layer
effects associated with the use of the POCIS. Their work,
however, showed the o-DGT to be a robust, sensitive and
reliable monitoring tool for these classes of analytes.
Recently, Buzier et al. (2019) in a laboratory study looked at
the effects of water flow (quiescent and flow 2–18 cm s−1) on
the uptake of ten pharmaceuticals by both the POCIS (with
added PRCs) and o-DGT. Results showed that both devices
gave similar results under flow conditions, but the o-DGT is
more efficient under quiescent conditions. This work showed,
however, that the o-DGT suffered from poor sensitivity due to
the size of the active sampling area (3.1 cm2), but that this
could potentially be overcome in the future by the use of a
larger sampler (Urik and Vrana 2019).
We undertook a similar study, but here comparing the field
performance and sampling efficiency of the Chemcatcher®
versus the POCIS. Both devices contained the same type
(Oasis® HLB) and amount (200 mg) of receiving phase sor-
bent but were retained in different formats (bound and un-
bound). Hence, it was thought that both polar devices would
behave similarly. Samplers were exposed for 21 days in the
effluent of three different WWTP in Wales, UK. We used
liquid chromatography/quadrupole-time-of-flight-mass spec-
trometry (LC/Q-ToF-MS) analysis combined with various sta-
tistical tools, to investigate the reproducibility of the integrated
chromatographic peak areas of targeted pharmaceutical sub-
stances identified during the screening of extracts against an
in-house database of pharmaceutical compounds. It was not
the objective of this study to measure the compound specific
uptake rate (Rs) for each of the pharmaceutical compounds
identified, as this was beyond the scope of the work and would
also be prohibitive based on cost and labour considerations.
Hence, TWA concentrations were not estimated in this study.
Materials and methods
Glassware, reagents and standards
Reagents and solvents were of analytical reagent grade or
better. Acetone, ammonium acetate, ammonium formate, di-
chloromethane, formic acid, methanol, methyl-tert-butyl ether
(MTBE), Sylon CT™ solution (5% dimethylchlorosilane in
toluene) and toluene were obtained from Fisher Scientific, UK
(Loughborough, Leicestershire, UK) or Sigma-Aldrich
(Gillingham, Dorset, UK). Pharmaceutical standards (164
compounds, 5 mg, purity ≥ 95%) used to develop the LC/Q-
ToF-MS database were purchased from Sigma-Aldrich
(Table S1). Stock and dilute working solutions were prepared
as described in the SupplementaryMaterial and kept at 3–5 °C
for up to 1 month. Ultrapure water (ELGA Purelab Ultra,
Marlow, Buckinghamshire, UK) was used in all laboratory
p r o c edu r e s . A l l g l a s swa r e wa s s i l a n i s ed ( 5%
dimethylchlorosilane in toluene). This was to reduce surface
activity of the glass surfaces and thereby prevent any loss of
analytes through adsorption.
Passive samplers
POCIS
Supor® 100 PES membrane (30 cm × 15 m, 0.1 μm pore size)
was purchased from Pall Corporation (Portsmouth, UK).
Oasis® HLB sorbent (receiving phase) was purchased from
Waters Chromatography Ireland Ltd. (Dublin, Ireland) as a
loose powder. Stainless steel (316 grade) ‘O’ rings, were made
by A.T. Engineering (Tadley, Hampshire, UK). PES mem-
branes (18 cm × 9 cm) were cut from the roll and cleaned prior
to use to remove polyethylene glycol impurities present in
their manufacture. The procedure used was similar to that
described by Guibal et al. (2015). The cut PES membranes
were soaked twice (24 h, 40 °C) in methanol/water (20%) and
then this procedure was repeated using only a methanol wash.
Cleaned membranes were placed on aluminium foil and dried
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(~ 8 h). Once dry, they were placed in a storage can (stainless
steel), being flushed with argon and kept at − 18 °C until use.
Six grams of Oasis® HLB sorbent (enough for 30 devices)
was placed in a glass chromatography column. The sorbent
was washed (250 mL) in sequence with methanol, methyl-
tertiary-butyl ether (MTBE), dichloromethane and again
methanol. The cleaned sorbent was removed, thoroughly
dried in a centrifugal rotary vacuum evaporator (Genevac
Rocket™, Genevac Ltd., Ipswich, UK) and then placed in a
sealed glass jar until use. Two hundred (± 2.0) milligram of the
purified Oasis® HLB was used for each POCIS device. The
sorbent was spread out and sandwiched between two PES
membranes and clamped together using two ‘O’ rings. The
‘O’ rings were secured firmly using three self-locking stain-
less steel bolts (Fig. S1). Once prepared devices were wrapped
in aluminium foil and stored in clean, sealable metal cans at −
20 °C until deployment. PRCs were not used in this trial as
their effectiveness with polar passive samplers is not proven
(Buzier et al. 2019).
Chemcatcher®
Three-component PTFE Chemcatcher® bodies (Atlantic de-
sign, A.T. Engineering) (Fig. S2) were soaked overnight in
10% Decon® detergent, washed thoroughly in water then
rinsed in methanol. The components were then allowed to
dry. Horizon Atlantic™ HLB-L disks (47 mm containing
200 mg of sorbent) (ARC Sciences Ltd., Alton, UK) were
used as the receiving phase. Disks were soaked overnight in
methanol and allowed to dry. The disks were then placed in a
vacuum filter funnel manifold andmethanol (50mL) followed
by water (50 mL) allowed to pass through under gravity. The
conditioned disks were removed and placed in water until use.
Disks (51 mm diameter) of Supor® 200 polyethersulphone
membrane (0.2 μm pore size) (Pall Corporation) were
punched from a roll and washed and stored as described for
the preparation of the POCIS membranes. The prepared HLB-
L disks were placed on the support body of the Chemcatcher®
and a clean PES membrane placed on the top of the disk. The
PTFE retaining ring, that holds the disk and membrane in
place, was screwed onto the Chemcatcher® body and firmly
tightened. It was important to ensure that no air was trapped
between the two layers. The assembled Chemcatcher® sam-
plers were stored (3–5 °C) submerged in water until use. PRCs
were not used in the trial. Prior to transport to the field, a clean
PTFE lid was fitted to each device.
Extraction
POCIS
After deployment, POCIS was removed from its deployment
holder, cleaned with water to remove any external fouling and
allowed to dry overnight. The device was opened, and the
exposed HLB sorbent was dried overnight. The sorbent was
transferred from the PESmembrane by carefully brushing into
a pre-weighed glass vial (15 mL). The sorbent is electrostatic
when dried, so special precautions were undertaken to mini-
mise losses during the transfer operation. The mass of sorbent
recovered from each deployed POCIS was recorded. The sor-
bent was then quantitatively transferred to a polypropylene
solid-phase extraction (SPE) cartridge (15 mL) fitted with a
PTFE frit. Using an SPE vacuum elution system, the seques-
tered compounds were eluted using methanol (40 mL) at a
flow rate of ~ 1 mLmin−1 with the eluate collected into a glass
vial (50 mL). The methanol was reduced in volume to ~
0.5 mL using a Genevac Rocket™ set to the low boiling point
mode. Each extract was resolvated with methanol to 1.0 mL,
and then transferred to a silanised glass vial (2 mL). Prior to
analysis, the extract was diluted (× 10) using mobile phase B
(an aqueous solution of 10% of methanol, 5 mM ammonium
formate and 0.01% formic acid). The dilution step minimised
matrix effects during the subsequent instrumental analysis.
Chemcatcher®
After exposure, Chemcatcher® samplers were carefully
cleaned with water to remove any bio-fouling and
disassembled. The PES membrane was discarded. Residual
moisture was removed from the HLB-L disk by drying (~
1 h) on a vacuum manifold. Analytes were then extracted
under gravity using small aliquots of methanol (total
40 mL), being collected into glass vials (50 mL). The subse-
quent analytical steps were as described above for the POCIS.
Field trial sites and sampler deployments
Chemcatcher® and POCIS devices were deployed in the final
effluent channel (in order to minimise ragging and biofouling
of the samplers) at three similarly designed WWTP located in
South Wales, UK, covering the areas of Carmarthen,
Gowerton (west Swansea) and Llanelli. Permission was ob-
tained from the site operators to deploy the samplers. WWTP
A (latitude 51.8358 longitude − 4.3268) treats wastewater
from a population equivalent of ~ 22,000 and effluent from a
local General Hospital, located 4.5 km north of the works.
WWTP B (latitude 51.6545 longitude − 4.0323) treats waste-
water from a population equivalent of ~ 50,000. WWTP C
(latitude 51.6636 longitude − 4.1098) treats wastewater from
a population equivalent of ~ 55,000 and also effluent from a
local hospital. At WWTP B two deployment rigs (WWTP B
(1) and WWTP B (2)) that were placed adjacent to each other
were used in order to assess the variability of uptake between
samplers at the same site. Triplicate Chemcatcher® (Fig. S3)
and POCIS samplers (Fig. S4) were used at each site. The
Chemcatcher® transport lid was removed and the POCIS
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was taken from its storage can and attached to stainless steel
holders then placed inside a stainless steel cage for protection.
Chain (5 mm) was used to fix the deployment cages to a
platform covering the final effluent channels at the three sites
(Fig. S5), where the average flow rates were 81 L s−1 (WWTP
A), 194 L s−1 (WWTP B) and 255 L s−1 (WWTP C). All
samplers were deployed for 21 days between 4th and 25th
of August 2014. This time period was selected to ensure ade-
quate sequestration of analytes for subsequent analysis. Over
this period, it was expected that most compounds would still
be in the time integrative regime whilst a few may have
approached equilibrium. At each site, during deployment
and retrieval operations, a field blank sampler for each design
was exposed to the air then resealed.
LC/Q-ToF-MS analysis
Chromatographic separation of the substances in the
pharmaceutical standards mix (Table S1) and those
found in the extracts from the passive sampling devices
(deployed and field blanks) was carried out using an
Agilent 1290 Infinity ultra-high performance liquid
chromatography (UHPLC) (Agilent Technologies, Santa
Clara, USA) system fitted with an Atlantis T3 (2.1 mm
i.d. × 150 mm, 3.5 μm particle size) (Waters, Elstree,
UK) column. The UHPLC system was interfaced to an
Agilent G6540A Q-ToF-MS equipped with a dual spray
jet stream electrospray ionisation source (ESI). A refer-
ence mass solut ion was injec ted cont inuously
(10 μL min−1) to the reference sprayer (using nitrogen
gas at 5 psi). The second sprayer delivered the column
eluent to the ESI source. The Q-ToF MS instrument
gathered data (2 GHz) using the extended dynamic
range mode with both positive and negative ion ESI
for the targeted chemicals. Sample data (molecular ad-
duct ions and their isotopes) was acquired (Agilent
Mass Hunter acquisition software (rev. B.06.01)) using
‘all Ions MS/MS’ mode (i.e. alternating low/high colli-
sion cell energy setting). All stored data was then ad-
justed using the reference lock mass correction. Further
details of the UHPLC and Q-ToF-MS analytical condi-
tions are given in Tables S2 and S3.
Data analysis to identify and quantify the pharmaceu-
tical compounds in the Chemcatcher® and POCIS ex-
tracts followed a typical LC/MS-based metabolomics
workflow. This involved (i) compound extraction from
targeted analysis (ii) alignment of peak retention time
(iii) integration of peak area and (iv) export of data
for statistical evaluation using Agilent Mass Profinder
in conjunction with Microsoft Excel and Minitab soft-
ware (Gravell 2017). Further details of the development
of the compound database library and procedures used
are given in the Supplementary Material and Table S4.
Results and discussion
As POCIS and Chemcatcher® are of similar design and use
the same receiving phase sorbent, it was expected that both
would sequester a similar range of chemicals, but with varying
amounts, at the three WWTP deployment sites. There was a
difference in the pore size of the PES membrane; the POCIS
used 0.1 μm pore size, whilst the Chemcatcher® used 0.2 μm
pore size, although this difference was not thought to signifi-
cantly influence uptake rates due to the small molecular size
(< 1000 Da) of the compounds sequestered. Both types of
samplers were deployed in the same protective cage; hence,
any effects on uptake due to the design of the deployment
apparatus were minimised. No sampler was lost during the
field trial. There was limited fouling of the PES membrane
even after a 3-week deployment in the final effluent channel.
No pharmaceutical substances that were in the compound da-
tabase library were detected in the exposed field blank
samplers.
Sorbent receiving phase
Upon disassembly of the POCIS, it was noted that the HLB
sorbent was unevenly distributed between the PES mem-
branes (Fig. S6). It was evident that the loose powder had
flowed and sagged toward the base of the device during ver-
tical deployment. This potentially reduced the active sampling
surface area and could have led to increased variability in
uptake rate for the pharmaceutical compounds (Mills et al.
2014). Such effects could be reduced by placing the samplers
in the horizontal plane during field deployments (Seen et al.
2014). In the Chemcatcher® the HLB sorbent in the receiving
phase disk is immobilised and hence the active sampling area
should have remained constant during the field deployments
(Fig. S7).
We found losses of sorbent occurred when disassembling
the POCIS in the laboratory and/or during the deployment
(Gravell 2017). The losses varied considerably between de-
vices and across all three deployment sites (Table 1). An over-
all average of 70% (RSD = 15%) of sorbent was recovered
from the original 200 mg that was added to each device.
Significantly lower amounts of sorbent, 104 mg and 97 mg,
were recovered from the POCIS deployed at WWTPA (sam-
pler 1) andWWTPC (sampler 2) respectively. The reasons for
these high losses is unknown. To our knowledge, such losses
have not been reported by other workers who have used the
POCIS in field studies; it is generally assumed the same mass
of sorbent initially added during the preparation stage is re-
covered during disassembly and analysis. Furthermore, the
HLB sorbent when dry becomes electrostatic and special pre-
cautions may be required to prevent static build-up; this effect
is often neglected or not mentioned in the published literature.
We carefully removed the HLB sorbent from the PES
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membrane prior to extraction and analysis. Often, however, it
is suggested that the PES membrane from POCIS deploy-
ments be placed directly in a glass funnel and methanol used
to wash the sorbent off into a receptacle. This can result in the
desorption of compounds which have been adsorbed onto the
PES membrane during deployment (Vermeirssen et al. 2012).
POCIS may be considered a mono-phasic sampler (Fauvelle
et al. 2014). Hence, equations used to calculate uptake rates
consider only what is adsorbed onto the sorbent. Inaccurate
results may be obtained if compounds that are adsorbed onto
the membrane are also measured and included in any uptake
rate estimations. This contrasts the Chemcatcher® as this con-
siders only compounds that have passed through the mem-
brane and subsequently adsorbed onto the sorbent and glass
fibre matrix of the disk (Gravell 2017).
As there were substantial losses of sorbent from the POCIS
during the deployment and analysis steps a recovery correc-
tion factor was used (Table 1). This was applied to all the
compound integrated peak areas derived from the LC/Q-
ToF-MS analyses. The use of this correction factor permitted
the direct comparison of the compound uptake in both types of
samplers. It was assumed that no losses of sorbent occurred
with the Chemcatcher® as the material is immobilised within a
glass fibre matrix. The use of commercially available and
quality-controlled receiving phases as used with the
Chemcatcher® allows for simplicity of use when compared
with some other designs of passive sampling devices.
Identification of pharmaceutical compounds
Using the compound database library, 72 pharmaceuticals
were identified in the passive sampler extracts (Table 2).
Sixty-eight compounds were present at all three sites and in
both types of samplers. Atorvastatin, naproxen and terbinafine
were found only at the WWTP A site, whilst piroxicam was
found only at theWWTPC site. Sixty-seven compounds were
identified in the positive ion mode, 5 compounds in the neg-
ative ion mode with 13 substances detectable using both
ionisation modes (Table 2). For both samplers, the peak areas
obtained from positive ionmode for these 13 compounds were
generally higher than that obtained from negative ion mode;
therefore, the positive ion data were selected for subsequent
statistical analysis for comparing the performance of the two
devices. Of the five chemicals identified (negative ion mode
only), four were acidic and hence did not efficiently ionise in
positive ion mode due to their very low proton affinities. The
pharmaceutical compounds found at the wastewater sites cov-
ered a wide variety of therapeutic drug classes. Many of these
substances have been detected previously using the POCIS
with an HLB receiving phase (Baz-Lomba et al. 2017;
Godlewska et al. 2019; Guibal et al. 2018; Harman et al.
2012; Morin et al. 2013). Similarly, these compounds have
also been detected in wastewater effluent and receiving sur-
face waters using the polar Chemcatcher® (Petrie et al. 2016;
Rimayi et al. 2019).
The integrated peak areas (corrected for the loss of HLB
sorbent in the POCIS) obtained for each pharmaceutical
compound detected were averaged (n = 3), and percentage
relative standard deviations (% RSD) were calculated
(Table 2). Larger peak areas were obtained for the POCIS
due to its larger active sampling area (3.01 times bigger).
Percentage RSD’s varied between individual compounds
and between samplers deployed at the three sites, including
the duplicate cages at WWTP site B. RSD’s (%) obtained
from the positive ion analysis were generally higher for the
Chemcatcher® sampler at two sites (WWTP A and B), but
substantially lower than POCIS for the WWTP C site. The
variability in recovery of the sorbent obtained from the
POCIS for site C may have led to the higher % RSD’s.
There were 32 compounds where the % RSD exceeded
15% for the POCIS extracts. This was compared with 56
compounds for the Chemcatcher®. Lower RSD’s would
have been expected for the Chemcatcher® sampler as it uses
a bound-receiving phase sorbent and thereby should have
increased the reproducibility of the device.
One possible reason contributing to this observation was
the smaller peak areas, typically 2–3 times smaller than the
POCIS. Only 10 compounds exceeded 30% RSD in both
samplers with the largest error observed for loratadine
(165% RSD) in the POCIS. For the Chemcatcher® sampler,
RSD’s obtained from negative ion analysis were generally
lower across all sites. One compound (naproxen) in the
POCIS, exceeded 30% RSD in negative ion mode. As the
mass spectrometric response for each pharmaceutical com-
pound differs significantly this will also influence the %
Table 1 Amount and percentage recovery of HLB sorbent recovered
from POCIS deployed at the three WWTP sites in South Wales. Amount
of sorbent originally added was 200 mg (A)
Site Amount
of sorbent
recovered
(mg) (B)
Percentage
of sorbent
recovered
Recovery
correction
factor A/B
WWTPA, sampler 1 104 52 1.92
WWTPA, sampler 2 141 71 1.42
WWTPA, sampler 3 146 73 1.37
WWTP B1, sampler 1 144 72 1.39
WWTP B1, sampler 2 146 73 1.37
WWTP B1, sampler 3 126 63 1.59
WWTP B2, sampler 1 147 74 1.36
WWTP B2, sampler 2 151 78 1.32
WWTP B2, sampler 3 143 71 1.40
WWTP C, sampler 1 178 89 1.12
WWTP C, sampler 2 97 49 2.06
WWTP C, sampler 3 147 73 1.36
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Table 2 Percentage relative standard deviations (n = 3) based on the
integrated peak areas obtained for 72 pharmaceuticals identified using
the compound database library in Chemcatcher® and POCIS sampler
extracts at the four different deployments using LC/Q-ToF-MS. POCIS
data corrected for the loss of sorbent during deployment and analytical
transfer operations. The table was adapted from Gravell (2017)
Compound WWTPA
Chemcatcher®
WWTPA
POCIS
WWTP B (1)
Chemcatcher®
WWTP B (1)
POCIS
WWTP B (2)
Chemcatcher®
WWTP B (2)
POCIS
WWTP C
Chemcatcher®
WWTP C
POCIS
Alfuzosin 27.9 12.5 1.8 6.4 16.2 5.7 17.4 1.5
Alverine 12.9 7.4 11.6 5.1 5.6 3.8 27.2 8.1
Amisulprideb 12.8 5.7 9.1 5.8 6.5 2.6 3.9 3.4
Amitriptyline 15.8 18.7 9.0 3.5 6.2 4.9 4.8 14.2
Atenolol 7.5 7.2 8.4 3.4 4.6 1.9 3.5 3.1
Atorvastatin 21.8 32.4 nd nd nd nd nd nd
Betamethasone
17 valerate
23.1 32.7 14.6 19.2 15.2 31.5 12.4 8.1
Bezafibrate 18.3 6.9 8.0 6.6 6.9 3.1 3.2 10.1
Bisoprolol 13.9 4.2 9.3 3.7 10.2 3.3 3.6 4.0
Carbamazepine 13.3 6.9 8.9 4.1 7.3 1.8 3.0 3.0
Cefalexin 14.2 4.9 9.9 4.8 11.0 6.1 3.5 9.4
Celiprololb 16.9 6.8 7.6 4.6 7.9 1.5 1.3 2.1
Cetirizine 13.0 4.0 6.2 3.1 7.8 2.5 3.0 4.5
Chlorpheniramine 19.2 8.6 25.3 15.1 5.9 33.2 32.1 20.9
Citalopram 14.1 8.2 7.8 3.8 6.8 4.2 3.8 11.8
Clarithromycinb 37.5 5.8 5.2 2.7 4.9 4.7 4.9 15.7
Clopidogrel 12.3 19.2 6.3 3.3 7.2 1.5 9.5 9.5
Cyclizine 13.2 4.5 6.8 1.7 9.1 2.3 3.6 5.8
Diclofenac 11.0 5.9 7.9 4.6 3.8 3.3 2.9 2.0
Diltiazem (cis) 24.6 7.4 7.1 3.0 8.8 4.2 4.0 12.4
Dipyridamole 24.0 5.0 9.1 6.5 6.2 5.4 5.0 3.7
Doxazosin 49.5 30.2 28.3 14.3 24.0 20.6 2.7 8.3
Erythromycinb 27.1 5.4 6.9 3.3 8.3 4.1 0.8 13.5
Fexofenadineb 15.1 5.0 8.2 3.8 8.1 3.4 3.4 7.0
Flecainideb 25.7 3.9 6.8 4.9 22.5 3.2 5.4 8.2
Fluconazoleb 8.5 10.7 5.0 7.4 7.4 3.1 9.0 3.5
Furosemide 3.8 15.6 0.6 6.6 7.9 9.4 6.2 12.5
Gliclazide 12.9 9.9 24.5 3.4 6.1 4.5 2.5 2.1
Ibuprofena 6.2 10.4 4.8 7.5 5.0 7.8 6.2 11.7
Indapamidea 4.9 9.0 3.2 7.1 3.1 4.5 2.7 1.3
Irbesartanb 14.1 3.2 7.0 3.5 7.7 2.7 4.1 4.9
Ketoconazole 26.3 5.8 11.4 3.3 8.3 2.7 3.5 14.2
Ketoprofen 12.4 17.6 6.7 2.4 24.2 14.9 24.6 7.3
Labetalol 12.0 1.1 10.1 3.7 7.1 1.2 0.5 11.0
Lamotrigine 9.5 9.6 10.5 3.6 5.5 1.1 2.0 2.0
Lansoprazole 10.1 8.2 10.4 3.9 8.8 2.2 3.1 9.8
Lidocaine 12.3 7.0 6.8 1.8 8.6 1.8 3.8 3.2
Loperamide 18.3 6.7 14.2 2.5 3.2 5.7 11.7 13.7
Loratadine 23.0 97.7 22.0 164.7 18.2 5.1 15.0 22.1
Losartan 14.4 4.0 10.8 5.4 1.0 6.3 7.0 3.8
Mefenamic acida 11.0 2.9 8.6 5.7 7.3 3.2 2.4 5.1
Metoclopramide 12.8 8.4 10.3 2.1 4.6 1.8 2.7 3.7
Metoprolol 13.4 10.6 7.5 5.5 9.5 1.2 3.5 3.7
Mirtazapine 11.7 3.6 10.0 4.4 8.5 3.0 3.1 3.6
Naproxena 10.7 34.6 nd nd nd nd nd nd
Nifedipine 32.0 45.7 47.8 18.2 24.0 13.4 9.3 28.5
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RSD obtained, as smaller responses will generally lead to
larger overall errors.
Comparison of uptake of pharmaceuticals by
Chemcatcher® versus POCIS
The integrated peak areas for each of the 68 compounds iden-
tified at all sites were used to compare the performance of the
two devices. As both data sets had an independent error dis-
tribution a simple linear regression analysis was not appropri-
ate; instead an orthogonal regression or Deming regression
(Cornbleet and Gochman 1979) was used. This approach is
different than with ordinary least squares regression. With
least square regression, the (x) or predictor value is a fixed
variable with no error. The (y) dependent variable has all of
the error is associated with it. The fitted line with the least
square regression always gives the minimum deviation of
the y values from the fitted line. The fitted line in orthogonal
regression corresponds to the minimum deviations at right
angles to the fitted line. This is equivalent to the first principal
component (Cornbleet and Gochman 1979). With orthogonal
regression, the interpretation of the regression parameters is
similar to that for the least squares. In order to fit an orthogonal
regression, it is necessary to have an estimate of the variance
ratio based on the experimental error for the two samplers.
This was obtained using a data set (n = 8796 observations)
based on the integrated peak areas of the unknown com-
pounds also found in the LC/Q-ToF-MS analyses at the same
sites as for the targeted pharmaceutical analyses. The esti-
mates of the experimental errors were calculated using a
two-way analysis of variance of the data (Table S5). The var-
iance associated with the compound, site and a compound-site
interaction term was removed from the total variation and the
residual error was representative of the experimental error.
Table 2 (continued)
Compound WWTPA
Chemcatcher®
WWTPA
POCIS
WWTP B (1)
Chemcatcher®
WWTP B (1)
POCIS
WWTP B (2)
Chemcatcher®
WWTP B (2)
POCIS
WWTP C
Chemcatcher®
WWTP C
POCIS
Omeprazole 16.4 1.8 6.9 3.9 7.4 6.6 6.0 10.3
Oxprenololb 2.5 7.9 6.7 7.1 4.8 4.0 3.1 4.4
Pantoprazole 11.7 12.8 26.6 6.3 20.3 5.1 7.1 8.8
Phenytoin 13.1 13.9 6.5 6.6 8.6 1.2 4.6 4.4
Piroxicam nd nd nd nd nd nd 3.7 3.2
Procyclidine 20.2 8.1 6.0 3.9 7.8 6.5 6.5 7.9
Propranolol 13.6 3.3 7.7 3.8 6.9 2.4 4.4 6.5
Quinine 15.6 4.7 11.3 3.4 14.6 3.7 3.3 5.5
Ranitidine 20.7 32.2 31.2 19.2 16.5 15.8 1.9 21.8
Salbutamol 4.2 10.7 9.2 1.4 43.1 4.6 4.7 5.8
Salicylic acida 8.7 15.1 13.3 2.9 12.6 11.4 3.9 14.1
Sertraline 20.6 22.1 11.8 3.4 1.7 4.1 6.2 11.2
Sotalolb 9.2 8.5 7.9 4.0 5.7 2.5 3.1 2.5
Sulfasalazine 10.9 4.7 6.7 5.7 5.3 0.9 3.8 5.6
Sumatriptanb 11.6 9.0 14.4 5.3 5.2 3.9 2.5 5.9
Tamsulosin 28.4 5.0 29.1 5.7 11.1 15.9 23.5 27.6
Telmisartan 14.9 11.1 7.6 5.2 4.9 1.2 6.0 8.9
Terbinafine 35.8 17.0 nd nd nd nd nd nd
Timolol 32.2 19.5 18.5 12.3 22.2 15.8 8.3 10.2
Tramadolb 12.8 5.9 8.2 4.4 8.0 1.5 3.5 0.2
Trazodone 27.5 25.0 6.6 3.8 10.3 0.6 6.3 7.0
Trimethoprim 13.4 8.4 7.5 3.6 8.1 0.9 3.8 0.2
Valsartanb 23.6 4.5 18.1 17.2 6.2 8.4 5.0 13.1
Venlafaxine 13.5 6.8 7.8 4.3 7.4 2.5 3.4 0.3
Verapamil 31.0 12.2 2.2 2.7 7.4 5.1 3.0 12.7
Warfarin 16.8 9.0 10.1 5.6 6.6 2.5 14.8 8.7
a Obtained from negative ion data
b Identified in both positive and negative ionisations
RSDs expressed as a percentage. All the other compounds were identified in positive ionisation. nd, not detected in extract
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The variance ratios (POCIS:Chemcatcher®) for the untrans-
formed and log10 transformed data were 14.59 and 1.92
respectively.
Normal probability plots for the untransformed data
showed a large skew (Fig. S8) with log10 transformation ren-
dering the data approximately normal (Fig. S9). Therefore,
subsequent orthogonal regression analysis used the log10
t ransformed data . The regress ion equat ion was
log10POCIS = 0.264 + 1.022 log10Chemcatcher and the fitted
line is shown in Fig. 1. Taking the anti-log10 of the intercept
gave the ratio of the uptakes by POCIS and Chemcatcher® of
1.84x. The analysis of variance output for the transformed
regression is shown in Table S6.
The ratio of the uptake of the pharmaceuticals for the
POCIS versus Chemcatcher® was lower (1.84x) than would
be expected on the basis of the ratio of active sampling areas
(3.01x) of the two devices. The reasons for this difference are
hard to determine; one explanation may be due to the sorbent
material in the POCISmoving slightly between the PESmem-
branes when the device was deployed in the vertical plane in
the deployment cage (Fig. S6). This would decrease the active
sampling area of the POCIS and thereby reduce uptake of the
analytes (Mills et al. 2014).
An analysis of variance (three-way ANOVA) of the 68
pharmaceuticals identified in the sampler deployments at the
four sites was undertaken for the log10 integrated peak areas
(Table S7). A log10 transformation was used because it im-
proved the variance stability greatly over the untransformed
data (Fig. S10). The treatments were pharmaceutical, site and
sampler. Every interaction term was included. All of the ef-
fects and interaction terms were significant. A multiple com-
parison of the site means using a Bonferroni probability test
(Table S8) showed that there were small but statistically sig-
nificant differences between the overall site means. Site
WWTP B2 (308,000) was different from all other sites, whilst
WWTP B1 (319,000) and WWTP C (320,000) were not sig-
nificantly different and WWTP A (414,000) was different
from the other three sites. The differences between the overall
site means for all of the compounds and both sampler types
were relatively small compared with the differences between
samplers (Chemcatcher® (218,000) and POCIS (523,000)).
An analysis of variance (two-way ANOVA) of the 68 phar-
maceuticals identified in the sampler co-deployments at
WWTP B site was undertaken for the log10 integrated peak
areas for each sampler type (Tables S9 and S10). Sample
repeat and compound were selected as factors. An interaction
between sample repeat and compound was also calculated.
There was no significant difference between the two parallel
deployments for Chemcatcher® F1,274 = 0.267), and the inter-
action termwas not significant (F66,274 > 0.999). However, for
POCIS there was a significant (F1,274 = 0.013) difference be-
tween the parallel deployments, but again no significant
(F66,274 > 0.999) interaction. The differences between the
two deployments for POCIS at WWTP B were much smaller
than those between WWTP B and the other sites. These ob-
servations may be attributed to the movement of sorbent ma-
terial within the POCIS during deployments.
Conclusions
The two samplers behaved similarly and sequestered the
same range of pharmaceutical compounds that were present
in the final effluent at three different WWTP. However,
there were substantial losses of sorbent material from the
POCIS during deployment and the subsequent analytical
steps. These losses are often ignored by end-users of the
device, but a recovery factor should be considered in the
future to improve the overall reliability of the resultant data.
Our data showed the uptake ratio between the two devices
was lower than that predicted based solely on the difference
between their active sampling areas. The most likely con-
tributory factor was the movement of sorbent material with-
in the POCIS during deployment in the vertical plane
throughout the field trials significantly reducing the theo-
retically available surface area for compound adsorption.
To minimise this movement it may be beneficial for end-
users to deploy the device horizontally in the deployment
cage. When comparing uptake rates (Rs values) between the
two devices and where the POCIS has been deployed in the
vertical plane, we recommend that the ratio of 1.84 is used
as a comparative factor in the future by end-users.
Fig. 1 Fitted line (―) from the log10 transformed orthogonal regression
analysis for the integrated peak areas (○) for the 68 pharmaceutical
compounds found at all sites (including duplicate deployment at
WWTP 2 site) using the Chemcatcher® and POCIS. The regression
equation was log10POCIS = 0.264 + 1.022 log10Chemcatcher
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